AstraZeneca taps Zook as president of biotech division

LONDON Anglo-Swedish drug maker AstraZeneca has appointed a new president for its biotech division.

Tony Zook will take over as president of MedImmune, replacing David Mott, who left the company in July, following MedImmune’s acquisition by AstraZeneca last year. Zook will also be in charge of the company’s global marketing operations and its divisions in the United States and Canada.